Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion
Kalra, Ashish V, Kim, Jaeyeon, Klinz, Stephan G, Paz, Nancy, Cain, Jason, Drummond, Daryl C, Nielsen, Ulrik B, Fitzgerald, Jonathan B
Published in Cancer research (Chicago, Ill.) (01.12.2014)
Published in Cancer research (Chicago, Ill.) (01.12.2014)
Get full text
Journal Article